Hanall Biopharma Co.,Ltd (009420.KS)

KRW 32650.0

(-6.18%)

Annual Balance Sheets

(In KRW)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 239.74 Billion 213.45 Billion 198.47 Billion 220.13 Billion 191.38 Billion 162.3 Billion
Total Current Assets 113.57 Billion 111.78 Billion 118.81 Billion 129.36 Billion 134.29 Billion 128.4 Billion
Cash And Short Term Investments 56.49 Billion 53.93 Billion 80.56 Billion 90.7 Billion 95.43 Billion 89.35 Billion
Cash and Cash Equivalents 33.72 Billion 16.84 Billion 12.79 Billion 4.2 Billion 6.12 Billion 22.68 Billion
Short Term Investments 22.77 Billion 37.09 Billion 67.77 Billion 86.5 Billion 89.31 Billion 66.67 Billion
Net Receivables 22.55 Billion 32.5 Billion 17.64 Billion 18.56 Billion 24.68 Billion 22.98 Billion
Inventory 32.38 Billion 25.18 Billion 20.4 Billion 19.89 Billion 13.71 Billion 15.51 Billion
Other Current Assets 2.14 Billion 163.01 Million 189.07 Million 204.06 Million 455.73 Million 553.25 Million
Total Non-Current Assets 126.16 Billion 101.66 Billion 79.66 Billion 90.76 Billion 57.08 Billion 33.89 Billion
Net PPE 19.43 Billion 19.12 Billion 19.04 Billion 15.48 Billion 14.93 Billion 13.76 Billion
Good Will And Intangible Assets 32.6 Billion 23.83 Billion 19.09 Billion 15.07 Billion 10.71 Billion 5.52 Billion
Good Will - - - - - -
Intangible Assets 32.6 Billion 23.83 Billion 19.09 Billion 15.07 Billion 10.71 Billion 5.52 Billion
Long-Term Investments 60.77 Billion 2.22 Billion -43.78 Billion -33.72 Billion -71.38 Billion -60.53 Billion
Tax Assets 6.97 Billion 8.54 Billion 12.21 Billion 3.2 Billion 6.89 Billion 3.23 Billion
Other Non Current Assets 6.37 Billion 47.92 Billion 73.08 Billion 90.73 Billion 95.92 Billion 71.9 Billion
Other Assets - - - - - -
Total Liabilities 53.52 Billion 45.19 Billion 34.98 Billion 38.85 Billion 50.96 Billion 45.38 Billion
Total Current Liabilities 37.65 Billion 28.53 Billion 22.11 Billion 23.06 Billion 27.38 Billion 21.8 Billion
Account Payables 11.27 Billion 4.75 Billion 1.75 Billion 4.94 Billion 4.29 Billion 2.83 Billion
Tax Payables 356.7 Million 919.82 Million 94.86 Million 818.23 Million 1.23 Billion 128.27 Million
Short Term Debt 700.22 Million 559.34 Million 423.43 Million 274.75 Million 367.49 Million -6.85 Billion
Deferred Revenue 9.86 Billion 8.26 Billion 18.03 Billion 15.8 Billion 19.98 Billion 6.85 Billion
Other Current Liabilities 15.81 Billion 14.95 Billion 1.9 Billion 2.03 Billion 2.73 Billion 18.97 Billion
Total Non Current Liabilities 15.87 Billion 16.66 Billion 12.86 Billion 15.78 Billion 23.58 Billion 23.58 Billion
Long-Term Debt 590.3 Million 751.05 Million 911.67 Million 276.75 Million 200.69 Million -
Deferred Revenue Non Current 14.41 Billion 15.29 Billion 11.22 Billion 14.16 Billion 21.99 Billion 20.46 Billion
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 876.21 Million 617.99 Million -50.00 1.34 Billion -150.00 3.12 Billion
Other Liabilities - - - - 10.00 -
Total Equity 186.21 Billion 168.25 Billion 163.49 Billion 181.27 Billion 140.41 Billion 116.91 Billion
Stock Holders Equity 186.21 Billion 168.25 Billion 163.49 Billion 181.27 Billion 140.41 Billion 116.91 Billion
Common Stock 26.12 Billion 26.12 Billion 26.12 Billion 26.12 Billion 26.12 Billion 26.12 Billion
Retained Earnings 26.38 Billion 29.41 Billion 26.38 Billion 17.59 Billion -5.32 Billion -23.55 Billion
Accumulated other comprehensive income 31.87 Billion 18.13 Billion 6.44 Billion 33.39 Billion 13.37 Billion 8.1 Billion
Common Stock Equity 186.21 Billion 168.25 Billion 163.49 Billion 181.27 Billion 140.41 Billion 116.91 Billion
Capital Lease Obligation 590.3 Million 1.31 Billion 1.33 Billion 551.51 Million 568.18 Million -
Total Investments 83.55 Billion 39.31 Billion 23.99 Billion 52.77 Billion 17.92 Billion 6.14 Billion
Total Debt 1.29 Billion 1.31 Billion 1.33 Billion 551.51 Million 568.18 Million -
Net Debt -32.43 Billion -15.53 Billion -11.45 Billion -3.64 Billion -5.55 Billion -22.68 Billion

Balance Sheet Charts